Recruiting Psoriatic Arthritis Studies in Chicago
Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen
The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA....
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis....
About Psoriatic Arthritis Clinical Trials in Chicago
Psoriatic arthritis is a form of inflammatory arthritis that affects some people with psoriasis, causing joint pain, stiffness, and swelling. It can affect any joint and varies in severity. Treatment includes NSAIDs, DMARDs, biologics, and JAK inhibitors.
There are currently 2 psoriatic arthritis clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 260 participants. Research is being sponsored by University of Chicago, Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriatic Arthritis Clinical Trials in Chicago — FAQ
Are there psoriatic arthritis clinical trials in Chicago?
Yes, there are 2 psoriatic arthritis clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Chicago?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.
Are clinical trials in Chicago free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.
What psoriatic arthritis treatments are being tested?
The 2 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for psoriatic arthritis.
Data updated March 2, 2026 from ClinicalTrials.gov